Similarities in HCMV and MCMV
Feature . | HCMV . | MCMV . |
---|---|---|
Prevalence | Worldwide seroprevalence: 45% to 100%50 | Seroprevalence: 61.7%, 79.4%, and 90%118-120 |
Multiple viral strains | Diverse viral isolates identified121,122 | Diverse viral isolates identified120,123 |
Life cycle | Primary, chronic, and latent infection | Primary, chronic, and latent infection |
Organ disease | Characteristic sites: lung, liver, and GI tract | Characteristic sites: lung, liver, and GI tract |
Unique immune responses | NK-cell memory: NKG2C+ NK cells64,65 | NK-cell memory: Ly49H+ NK cells62,63 |
CD8+ T-cell memory inflation124-126 | CD8+ T-cell memory inflation126,127 | |
Resistance to antiviral drugs | Mutations in HCMV DNA polymerase and UL97128-130 | Mutations in MCMV DNA polymerase and M97130 |
Feature . | HCMV . | MCMV . |
---|---|---|
Prevalence | Worldwide seroprevalence: 45% to 100%50 | Seroprevalence: 61.7%, 79.4%, and 90%118-120 |
Multiple viral strains | Diverse viral isolates identified121,122 | Diverse viral isolates identified120,123 |
Life cycle | Primary, chronic, and latent infection | Primary, chronic, and latent infection |
Organ disease | Characteristic sites: lung, liver, and GI tract | Characteristic sites: lung, liver, and GI tract |
Unique immune responses | NK-cell memory: NKG2C+ NK cells64,65 | NK-cell memory: Ly49H+ NK cells62,63 |
CD8+ T-cell memory inflation124-126 | CD8+ T-cell memory inflation126,127 | |
Resistance to antiviral drugs | Mutations in HCMV DNA polymerase and UL97128-130 | Mutations in MCMV DNA polymerase and M97130 |
GI, gastrointestinal.